Merck

MRK · NYSE · USD

$144.62−0.47%−$0.69

Close · October 1, 2026

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Item20252024202320222021
Total revenue65,01164,16860,11559,28348,704
Cost of revenue14,81514,69815,91517,20613,466
Gross profit50,19649,47044,20042,07735,238
Selling, general and administrative10,11510,1009,8849,6699,403
Research and development15,61414,48118,34211,91811,942
Operating income24,46724,88915,97420,49013,893
EBIT24,46724,88915,97420,49013,893
EBITDA29,10529,13419,70624,27917,016
Interest expense1,3571,2711,146962806
Pre-tax income21,06719,9361,88916,44413,879
Income tax2,8042,8031,5121,9181,521
Net income18,25417,11736514,51913,049
Net income to common shareholders18,25417,11736514,51913,049
Basic EPS7.306.760.145.735.16
Diluted EPS7.286.740.145.715.14
Average shares (basic)2,5022,5322,5372,5322,530
Average shares (diluted)2,5072,5412,5472,5422,538
Dividend per share3.243.082.922.762.60